Fong Bryant

Fong Bryant serves as a Director at ADMA Biologics, Inc., a company focused on developing and commercializing specialty biologics. His recent disclosures include two public filings as of February 28, 2024, all related to his role within the healthcare sector. The largest disclosed transaction involved the grant or exercise of options valued at approximately $202.7K.